tirzepatide phase 3 after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 trial Tirzepatide monotherapy in Chinese patients

We used the ICD10Data website to convert the ICD-9 codes used in the Hirsch and Jaff studies to corresponding ICD-10 codes for our analysis based on the 2020 data (ICD-9 codes were replaced by ICD-10 codes in 2015)

One hour, 4 hours, 12 hours

Insulin resistance and exendin-4 treatment for multiple system atrophy

Disclosure: Peter Singer owns shares in GLP-1 companies

Safety Concerns The proliferation of compounded GLP-1s was accompanied by safety concerns, largely because compounded drugs were not reviewed by the FDA prior to distribution

While these are common, they can lead to dehydration and kidney problems if not managed properly